DE1445580A1 - Neue Aminopyrazole - Google Patents

Neue Aminopyrazole

Info

Publication number
DE1445580A1
DE1445580A1 DE19631445580 DE1445580A DE1445580A1 DE 1445580 A1 DE1445580 A1 DE 1445580A1 DE 19631445580 DE19631445580 DE 19631445580 DE 1445580 A DE1445580 A DE 1445580A DE 1445580 A1 DE1445580 A1 DE 1445580A1
Authority
DE
Germany
Prior art keywords
radical
salts
pyridyl
acid
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19631445580
Other languages
German (de)
English (en)
Inventor
Eichenberger Dr Kurt
Wilhelm Dr Max
Schmidt Dr Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Publication of DE1445580A1 publication Critical patent/DE1445580A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19631445580 1962-01-23 1963-01-18 Neue Aminopyrazole Pending DE1445580A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH78762A CH440293A (de) 1962-01-23 1962-01-23 Verfahren zur Herstellung neuer Aminopyrazole

Publications (1)

Publication Number Publication Date
DE1445580A1 true DE1445580A1 (de) 1969-03-13

Family

ID=4195173

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19631445580 Pending DE1445580A1 (de) 1962-01-23 1963-01-18 Neue Aminopyrazole
DE19631545699 Pending DE1545699A1 (de) 1962-01-23 1963-01-18 Neue Aminopyrazole

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19631545699 Pending DE1545699A1 (de) 1962-01-23 1963-01-18 Neue Aminopyrazole

Country Status (5)

Country Link
US (2) US3228947A (US06262066-20010717-C00424.png)
BE (2) BE627394A (US06262066-20010717-C00424.png)
CH (1) CH440293A (US06262066-20010717-C00424.png)
DE (2) DE1445580A1 (US06262066-20010717-C00424.png)
GB (1) GB982613A (US06262066-20010717-C00424.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1295560B (de) * 1963-07-24 1969-05-22 Heyden Chem Fab Verfahren zur Herstellung von substituierten 5-Aminopyrazolen
US4347251A (en) * 1981-07-13 1982-08-31 American Cyanamid Company Novel 3-substituted amino-1-substituted heteroaryl-2-pyrazolines
CA2829790C (en) 2010-03-30 2018-06-05 Verseon Corporation Multisubstituted aromatic compounds as inhibitors of thrombin
BR112012033341B1 (pt) 2010-06-30 2022-08-23 Cyclerion Therapeutics, Inc Estimulantes de sgc
US9061030B2 (en) 2010-11-09 2015-06-23 Ironwood Pharmaceuticals, Inc. sGC stimulators
EP2797915B1 (en) 2011-12-27 2016-07-13 Ironwood Pharmaceuticals, Inc. 2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure
WO2014060381A1 (de) * 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
AU2014238478B2 (en) 2013-03-15 2018-07-19 Verseon Corporation Halogenopyrazoles as inhibitors of thrombin
MX2015012867A (es) 2013-03-15 2016-06-10 Verseon Corp Compuestos aromaticos multisustituidos como inhibidores de serina proteasa.
WO2016044662A1 (en) 2014-09-17 2016-03-24 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
SG10201907699YA (en) 2015-02-27 2019-09-27 Verseon Corp Substituted pyrazole compounds as serine protease inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3014038A (en) * 1961-12-19 Xnhxs
US2833779A (en) * 1956-10-29 1958-05-06 American Cyanamid Co Substituted pyrazoles
NL253320A (US06262066-20010717-C00424.png) * 1959-07-03
US3041343A (en) * 1959-10-14 1962-06-26 Sandoz Ltd 4-(thienyl-2'')-and 4-(pyridyl-3'')-5-aminopyrazoles

Also Published As

Publication number Publication date
DE1545699A1 (de) 1969-06-26
BE627393A (US06262066-20010717-C00424.png)
CH440293A (de) 1967-07-31
US3228947A (en) 1966-01-11
US3250761A (en) 1966-05-10
BE627394A (US06262066-20010717-C00424.png)
GB982613A (en) 1965-02-10

Similar Documents

Publication Publication Date Title
DE2404113A1 (de) 4-phenylpiperidine und ihre salze mit pharmazeutisch annehmbaren saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE1670849B2 (de) Verfahren zur herstellung von 8-acylamino-1,2,3,4-tetrahydroisochinolinen
DE2009555A1 (de) Neue Phenothiazinderivate
DE1445580A1 (de) Neue Aminopyrazole
DE1946172A1 (de) Neue heterocyclische AEther und Verfahren zu ihrer Herstellung
DE2605377A1 (de) 0-aminooxime, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2364685C3 (de) Phenoxyäthylamine
CH618439A5 (US06262066-20010717-C00424.png)
DE1445579A1 (de) Neue Aminopyrazole
DE2345951C2 (de) 1-(2,6-Dichlorphenylamidino)-harnstoff bzw. dessen Hydrochlorid, Verfahren zu seiner Herstellung und diesen enthaltende therapeutische Zubereitung
DE1212984B (de) Verfahren zur Herstellung von basisch substituierten Cumaronen
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
AT391866B (de) Verfahren zur herstellung neuer s-triazolo (1,5-a) pyrimidine
DE1229096B (de) Verfahren zur Herstellung von 2-substituierten 3-Amino-pyrazol-4-carbonsaeure-N'-[5-nitrofuryl-(2)-methyliden]-hydraziden
DE2166270A1 (de) Aminoaethansulfonylderivate
DE2265242C2 (de) Verfahren zur Herstellung von tautomeren 4-Phenyl-1,3-dihydro-2H-1,5-benzodiazepin-2-thionen
DE2406972B2 (de) Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren
CH639959A5 (de) 2,4-diamino-5-thiobenzylpyrimidine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
AT269136B (de) Verfahren zur Herstellung von neuen Isoxazolylpyridiniumsalzen
DE3121137A1 (de) Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung"
AT230884B (de) Verfahren zur Herstellung neuer 3-Aminopyrazole
DE1795384B2 (de) lH-2,3-Benzoxazine, Verfahren zu deren Herstellung sowie Arzneimittel
DE2312256C3 (de) 5-Pyrazol-essigsäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE2019719C3 (de) 1,3,4-Substituierte 5-Dimethylaminouracile und Verfahren zu ihrer Herstellung
DE931828C (de) Verfahren zur Herstellung von AEthylendiaminderivaten